scholarly article | Q13442814 |
P50 | author | Scott B Halstead | Q60059357 |
P2093 | author name string | Papaevangelou G | |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dengue hemorrhagic fever | Q18554268 |
Dengue virus | Q476209 | ||
P304 | page(s) | 46-51 | |
P577 | publication date | 1977-03-01 | |
P1433 | published in | Journal of Tropical Medicine and Hygiene | Q26842227 |
P1476 | title | Infections with two dengue viruses in Greece in the 20th century. Did dengue hemorrhagic fever occur in the 1928 epidemic? | |
P478 | volume | 80 |
Q36607295 | A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial |
Q33988937 | A single dose of the DENV-1 candidate vaccine rDEN1Δ30 is strongly immunogenic and induces resistance to a second dose in a randomized trial |
Q34883085 | Antibody to dengue 1 detected more than 60 years after infection |
Q35845829 | Daily newspaper view of dengue fever epidemic, Athens, Greece, 1927-1931 |
Q27491036 | Dengue Plaque Reduction Neutralization Test (PRNT) in Primary and Secondary Dengue Virus Infections: How Alterations in Assay Conditions Impact Performance |
Q30876552 | Dengue and chikungunya: long-distance spread and outbreaks in naïve areas |
Q35043859 | Describing the breakbone fever: IDODEN, an ontology for dengue fever |
Q27488300 | Emergence of the Severe Syndrome and Mortality Associated with Dengue and Dengue-Like Illness: Historical Records (1890 to 1950) and Their Compatibility with Current Hypotheses on the Shift of Disease Manifestation |
Q36756643 | Emergence potential of sylvatic dengue virus type 4 in the urban transmission cycle is restrained by vaccination and homotypic immunity |
Q34763787 | Heterotypic dengue infection with live attenuated monotypic dengue virus vaccines: implications for vaccination of populations in areas where dengue is endemic |
Q34144495 | Inferring the serotype associated with dengue virus infections on the basis of pre- and postinfection neutralizing antibody titers |
Q27490989 | Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4 30-4995 in Healthy Adult Volunteers |
Q27487377 | Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity |
Q98164941 | Sequential immunization induces strong and broad immunity against all four dengue virus serotypes |
Q34423720 | Variation in dengue virus plaque reduction neutralization testing: systematic review and pooled analysis |